“…Importantly, NDL PCBs represent a significantly greater percentage of the PCBs detected in human serum, adipose tissue, breast milk, and brain tissue from children diagnosed with a NDD [19,[54][55][56]. Although environmentally relevant exposures to dioxin and DL PCBs are associated with adverse outcomes in several organ systems, especially skin, liver and the immune system [57][58][59], and some are probably carcinogenic [60], there is little data demonstrating that DL PCBs are direct developmental neurotoxicants (but see [29,61,62]). In contrast, human, animal and mechanistic studies confirm the developmental neurotoxicity of legacy NDL PCBs [14,19,21,26,31,[63][64][65][66], and emerging evidence suggests that non-legacy LC-PCBs also pose a risk to the developing brain [67].…”